John Corbyn Cravero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
John Corbyn Cravero has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Collin Telchik
Division of Infectious Diseases, University of Texas Southwestern Medical Center
2 shared publications- Lauren Sisco
Division of Infectious Diseases, Baylor Scott & White Medical Center , Temple, Texas
2 shared publications - Andrea Grimbergen
Department of Internal Medicine, Baylor Scott & White Medical Center , Temple, Texas
1 shared publication Branden Brelsford
Division of Neurology, Baylor Scott & White Medical Center – Temple
1 shared publication- Christopher J. Peterson
Department of Internal Medicine, Virginia Tech Carilion School of Medicine, Roanoke, VA
1 shared publication - Collin Telchik
Department of Internal Medicine, Baylor Scott & White Medical Center , Temple, Texas
1 shared publication
Latest Publications
- 29 April 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83 (1) , 70-78
Interest in Infectious Diseases Among Internal Medicine Resident Physicians: Results From a Nationwide Survey
Background: Infectious diseases (ID) remain an essential specialty in medicine; however, fellowship applications have declined despite a growing shortage of ID physicians. As the need for an ID workforce increases, understanding the factors influencing internal medicine (IM) resident physicians’ decisions is crucial to guide recruitment. Methods: A 19-question cross-sectional survey was distributed to IM resident physicians across the United States to assess interest in ID and identify factors influencing specialty selection. Forty-one of 637 programs responded (6.4%) with 380 individual trainee survey responses. Results: Interest in ID was significantly associated with interest in public health (P < .0001), global health (P < .0001), and service-oriented careers (P = .016). Prior exposures, such as mentorship from an ID physician (P = .0002), completing an ID rotation during medical school (P = .0072), and shadowing outside of required rotations (P < .0001), were associated with increased interest. During residency, early exposure to ID in the first (PGY-1) and second (PGY-2) years (P = .044 and P = .0089), outpatient ID electives (P = .022), and ID-related research (P < .0001) were associated with increased interest. Common reasons cited for disinterest included low compensation, the need for additional training, long work hours, and limited procedural opportunities. Conclusions: Internal medicine residents interested in ID are more likely to report early exposure, mentorship, and alignment with interests in public or global health. Those not interested in ID commonly cited concerns about compensation, training length, and limited procedural opportunities. Recruitment strategies should address these barriers while also enhancing early engagement and mentorship opportunities.
- 29 April 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83 (1) , 70-78
Interest in Infectious Diseases Among Internal Medicine Resident Physicians: Results From a Nationwide Survey
Background: Infectious diseases (ID) remain an essential specialty in medicine; however, fellowship applications have declined despite a growing shortage of ID physicians. As the need for an ID workforce increases, understanding the factors influencing internal medicine (IM) resident physicians’ decisions is crucial to guide recruitment. Methods: A 19-question cross-sectional survey was distributed to IM resident physicians across the United States to assess interest in ID and identify factors influencing specialty selection. Forty-one of 637 programs responded (6.4%) with 380 individual trainee survey responses. Results: Interest in ID was significantly associated with interest in public health (P < .0001), global health (P < .0001), and service-oriented careers (P = .016). Prior exposures, such as mentorship from an ID physician (P = .0002), completing an ID rotation during medical school (P = .0072), and shadowing outside of required rotations (P < .0001), were associated with increased interest. During residency, early exposure to ID in the first (PGY-1) and second (PGY-2) years (P = .044 and P = .0089), outpatient ID electives (P = .022), and ID-related research (P < .0001) were associated with increased interest. Common reasons cited for disinterest included low compensation, the need for additional training, long work hours, and limited procedural opportunities. Conclusions: Internal medicine residents interested in ID are more likely to report early exposure, mentorship, and alignment with interests in public or global health. Those not interested in ID commonly cited concerns about compensation, training length, and limited procedural opportunities. Recruitment strategies should address these barriers while also enhancing early engagement and mentorship opportunities.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2026 (1) , 2502643
Emphysematous Pyelonephritis due to Candida glabrata and Candida tropicalis Bezoar: A Case Report
Emphysematous pyelonephritis (EPN) is a severe, necrotizing infection that can affect the renal parenchyma, collecting system, or perinephric tissue. Although typically caused by enteric Gram‐negative bacteria, infections secondary to Candida occur rarely. We present the case of a 72‐year‐old female who was transferred from an outside hospital with a chief complaint of abdominal pain in the setting of dislodged percutaneous nephrostomy tube for chronic hydronephrosis. Clinically, she presented without evidence of septic shock but was found to have elevated creatinine (6.04), concerning for acute renal failure. Urology was consulted and performed cystoscopy that showed a large bilateral mass consistent with fungal ball formation. Subsequent urine cultures speciated Candida tropicalis and Candida glabrata . Per infectious disease recommendations, the patient was initially started on treatment with fluconazole and flucytosine; however, fluconazole was switched to amphotericin B deoxycholate after sensitivities reported resistance to fluconazole for Candida tropicalis . Additionally, urology performed a bilateral percutaneous nephroscopy with ultrasonic lithotripsy for removal of her fungal bezoar on Day 22 of her hospitalization with subsequent nephrostograms that showed a patent genitourinary system. This case demonstrates successful treatment of EPN secondary to azole‐resistant Candida species using combined systemic antifungal therapy and an endourologic approach. This avoided the use of percutaneous nephrostomy irrigation with amphotericin deoxycholate as recommended in current guidelines and prevented potential complications this procedure carries.
- 1 January 2026
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2026 (1) , 2502643
Open AccessEmphysematous Pyelonephritis due to Candida glabrata and Candida tropicalis Bezoar: A Case Report
Emphysematous pyelonephritis (EPN) is a severe, necrotizing infection that can affect the renal parenchyma, collecting system, or perinephric tissue. Although typically caused by enteric Gram‐negative bacteria, infections secondary to Candida occur rarely. We present the case of a 72‐year‐old female who was transferred from an outside hospital with a chief complaint of abdominal pain in the setting of dislodged percutaneous nephrostomy tube for chronic hydronephrosis. Clinically, she presented without evidence of septic shock but was found to have elevated creatinine (6.04), concerning for acute renal failure. Urology was consulted and performed cystoscopy that showed a large bilateral mass consistent with fungal ball formation. Subsequent urine cultures speciated Candida tropicalis and Candida glabrata . Per infectious disease recommendations, the patient was initially started on treatment with fluconazole and flucytosine; however, fluconazole was switched to amphotericin B deoxycholate after sensitivities reported resistance to fluconazole for Candida tropicalis . Additionally, urology performed a bilateral percutaneous nephroscopy with ultrasonic lithotripsy for removal of her fungal bezoar on Day 22 of her hospitalization with subsequent nephrostograms that showed a patent genitourinary system. This case demonstrates successful treatment of EPN secondary to azole‐resistant Candida species using combined systemic antifungal therapy and an endourologic approach. This avoided the use of percutaneous nephrostomy irrigation with amphotericin deoxycholate as recommended in current guidelines and prevented potential complications this procedure carries.
- 4 September 2025
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 38 (6) , 843-850
Variations in West Nile viral infections across North and Central Texas
West Nile virus is a single-stranded RNA arbovirus with variable clinical presentation. To better understand the clinical characteristics, diagnostic evaluation, and outcomes, we performed a retrospective analysis of the Baylor Scott & White Health medical records for hospitalized adult patients with West Nile virus from January 1, 2015, to September 1, 2024. A total of 79 patients were included. Most were male (55.7%) with a mean age of 64.15 years. The highest concentration of cases was reported in Dallas County (34.2%) and Tarrant County (22.8%). Seventy-three patients (92.4%) had neuroinvasive disease, while 6 patients (7.8%) had nonneuroinvasive disease. Presenting symptoms included fever (73.43%), confusion (49.59%), and weakness (40.51%). Six patients (7.6%) were found to have acute ischemic stroke during their admission. Fifteen patients (18.99%) died. Cerebrospinal fluid analysis generally showed elevated protein (mean value 104.7 mg/dL) with either neutrophilic (mean 32%) or lymphocytic pleocytosis (mean 51.6%). None of the treatments analyzed (intravenous immunoglobulin, plasma exchange, and steroids) was found to have any significant effect on morbidity and mortality. West Nile virus is a common recurring disease across Texas. While some cases progress to neuroinvasive disease, there appears to be no meaningful way to predict these cases based on clinical and demographic data.
- 4 September 2025
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 38 (6) , 843-850
Variations in West Nile viral infections across North and Central Texas
West Nile virus is a single-stranded RNA arbovirus with variable clinical presentation. To better understand the clinical characteristics, diagnostic evaluation, and outcomes, we performed a retrospective analysis of the Baylor Scott & White Health medical records for hospitalized adult patients with West Nile virus from January 1, 2015, to September 1, 2024. A total of 79 patients were included. Most were male (55.7%) with a mean age of 64.15 years. The highest concentration of cases was reported in Dallas County (34.2%) and Tarrant County (22.8%). Seventy-three patients (92.4%) had neuroinvasive disease, while 6 patients (7.8%) had nonneuroinvasive disease. Presenting symptoms included fever (73.43%), confusion (49.59%), and weakness (40.51%). Six patients (7.6%) were found to have acute ischemic stroke during their admission. Fifteen patients (18.99%) died. Cerebrospinal fluid analysis generally showed elevated protein (mean value 104.7 mg/dL) with either neutrophilic (mean 32%) or lymphocytic pleocytosis (mean 51.6%). None of the treatments analyzed (intravenous immunoglobulin, plasma exchange, and steroids) was found to have any significant effect on morbidity and mortality. West Nile virus is a common recurring disease across Texas. While some cases progress to neuroinvasive disease, there appears to be no meaningful way to predict these cases based on clinical and demographic data.
- 19 August 2025
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 38 (6) , 801-805
A comparative analysis between transthoracic and transesophageal echocardiography in screening for infective endocarditis in patients with Staphylococcus aureus bacteremia
Infective endocarditis is commonly associated with Staphylococcus aureus bacteremia. While various guidelines regarding the need for echocardiography imaging exist, few studies directly compare transthoracic echocardiography (TTE) with transesophageal echocardiography (TEE). We performed a single institution retrospective study from January 1, 2015, through December 31, 2022, that compared the sensitivity of TTE and TEE in patients admitted with a diagnosis of S. aureus bacteremia. A total of 196 patients were included in the final analysis. Blood culture results revealed positivity for methicillin-susceptible S. aureus in 62.2% of cases and for methicillin-resistant S. aureus in 34.2% of cases. Thirty-six patients were excluded due to indeterminate imaging findings, leaving a subset of 160 for final analysis. Of this subset, 30 patients were found to have positive imaging findings on TTE and/or TEE. TEE detected 26 cases (87%), while TTE detected 7 cases (23%). TEE was significantly more sensitive than TTE (P = 0.0003). In patients with S. aureus bacteremia who underwent sequential TTE followed by TEE, TEE was significantly more sensitive than TTE for detecting imaging evidence of infective endocarditis.
- 19 August 2025
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 38 (6) , 801-805
A comparative analysis between transthoracic and transesophageal echocardiography in screening for infective endocarditis in patients with Staphylococcus aureus bacteremia
Infective endocarditis is commonly associated with Staphylococcus aureus bacteremia. While various guidelines regarding the need for echocardiography imaging exist, few studies directly compare transthoracic echocardiography (TTE) with transesophageal echocardiography (TEE). We performed a single institution retrospective study from January 1, 2015, through December 31, 2022, that compared the sensitivity of TTE and TEE in patients admitted with a diagnosis of S. aureus bacteremia. A total of 196 patients were included in the final analysis. Blood culture results revealed positivity for methicillin-susceptible S. aureus in 62.2% of cases and for methicillin-resistant S. aureus in 34.2% of cases. Thirty-six patients were excluded due to indeterminate imaging findings, leaving a subset of 160 for final analysis. Of this subset, 30 patients were found to have positive imaging findings on TTE and/or TEE. TEE detected 26 cases (87%), while TTE detected 7 cases (23%). TEE was significantly more sensitive than TTE (P = 0.0003). In patients with S. aureus bacteremia who underwent sequential TTE followed by TEE, TEE was significantly more sensitive than TTE for detecting imaging evidence of infective endocarditis.
- 28 April 2025
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 38 (4) , 421-426
A single-institution retrospective analysis on the administration of β-lactam antibiotics prior to vancomycin in bacteremic patients
The 2021 Surviving Sepsis Guidelines emphasize prompt antibiotic administration as a recommendation for septic patients. Instead of focusing solely on timing, we aimed to investigate whether the sequence of antibiotic administration influences mortality. This single-institution retrospective study included patients over 18 years old with confirmed bacteremia between January 1, 2021, and July 1, 2023, who received sequential antibiotic administration of intravenous β-lactam and vancomycin within the first 6 hours of admission. Our primary objective was to determine the odds ratio for 30-day mortality based upon antibiotic class administered first. Of 6143 patients generated from an electronic search, 222 patients were included in the β-lactam–first group, and 16 were included in the vancomycin–first group. The most common β-lactam antibiotic administered was piperacillin-tazobactam (58.40%) followed by cefepime (25.47%) and then ceftriaxone (13.03%). For patients with monomicrobial bacteremia, the most common bacterial infections included Escherichia coli (25.21%), methicillin-resistant Staphylococcus aureus (13.45%), methicillin-susceptible S. aureus (11.34%), and Proteus mirabilis (7.56%). The calculated odds ratio for 30-day mortality was 0.40 (95% confidence interval 0.089–1.831), indicating a decreased occurrence of mortality within 30 days for patients who received β-lactam antibiotics first, although this result was not statistically significant due to limited sample size, particularly within the vancomycin-first group. Although not statistically significant, the prompt administration of β-lactam antibiotics before vancomycin may confer a mortality benefit in patients with bacteremia. Further studies are needed to validate this finding.
- 28 April 2025
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 38 (4) , 421-426
A single-institution retrospective analysis on the administration of β-lactam antibiotics prior to vancomycin in bacteremic patients
The 2021 Surviving Sepsis Guidelines emphasize prompt antibiotic administration as a recommendation for septic patients. Instead of focusing solely on timing, we aimed to investigate whether the sequence of antibiotic administration influences mortality. This single-institution retrospective study included patients over 18 years old with confirmed bacteremia between January 1, 2021, and July 1, 2023, who received sequential antibiotic administration of intravenous β-lactam and vancomycin within the first 6 hours of admission. Our primary objective was to determine the odds ratio for 30-day mortality based upon antibiotic class administered first. Of 6143 patients generated from an electronic search, 222 patients were included in the β-lactam–first group, and 16 were included in the vancomycin–first group. The most common β-lactam antibiotic administered was piperacillin-tazobactam (58.40%) followed by cefepime (25.47%) and then ceftriaxone (13.03%). For patients with monomicrobial bacteremia, the most common bacterial infections included Escherichia coli (25.21%), methicillin-resistant Staphylococcus aureus (13.45%), methicillin-susceptible S. aureus (11.34%), and Proteus mirabilis (7.56%). The calculated odds ratio for 30-day mortality was 0.40 (95% confidence interval 0.089–1.831), indicating a decreased occurrence of mortality within 30 days for patients who received β-lactam antibiotics first, although this result was not statistically significant due to limited sample size, particularly within the vancomycin-first group. Although not statistically significant, the prompt administration of β-lactam antibiotics before vancomycin may confer a mortality benefit in patients with bacteremia. Further studies are needed to validate this finding.